• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

氨曲南(AZT)治疗复杂性尿路感染的临床评估

[Clinical evaluation of aztreonam (AZT) in the treatment of complicated urinary tract infections].

作者信息

Mizutani S, Iwao N, Miyoshi S, Kameoka H, Yano H, Kishimoto T, Sakurai T, Wakatsuki A, Nakamura T, Honda M

机构信息

Department of Urology, Osaka Rosai Hospital.

出版信息

Hinyokika Kiyo. 1989 Dec;35(12):2155-61.

PMID:2694836
Abstract

Aztreonam (AZT, Azactam) was given to 176 patients with complicated urinary tract infections (UTI), of whom 110 cases satisfied with the "Criteria of UTI Committee for the Evaluation of Drug Efficacy in the UTI (3rd Ed.)", which was modified by adopting the midstream urine data in cases of women. Aztreonam was administered by drip infusion at a daily dose of 1 to 4 grams (mostly 2 grams) for at least five days long. The overall clinical efficacy rate of AZT in the 110 cases with the complicated UTI was 64%, estimated by the criteria cited above. The efficacy rate according to the infection type groupings was 66% for the 38 patients in the 1st group, 33% for the 3 in the 2nd group, 79% for the 19 in the 3rd group, 85% for the 21 in the 4th, 47% for the 19 in the 5th and 42% for the 12 in the 6th group. The disappearance rate of Gram negative bacilli was 87.1%. Especially 15 strains of Pseudomonas aeruginosa were eliminated out of 25 (60%) after AZT administration. Forty-six strains appeared after AZT treatment, 36 (76%) of which were Gram positive cocci. Subjective side effects and abnormal laboratory findings in a total 176 cases were: diarrhea in one, upper abdominal discomfort in one, increases in glutamic pyruvic transaminase in 8, increases in glutamic oxaloacetic transaminase in 5 and eosinophilia in 1. All of these disappeared after termination of the drug. AZT might therefore be a useful and safe antibiotic for the first choice use against complicated UTI.

摘要

氨曲南(AZT,阿兹他啶)用于治疗176例复杂性尿路感染患者,其中110例符合“尿路感染药物疗效评估委员会标准(第3版)”,该标准在女性病例中采用了中段尿数据进行了修改。氨曲南通过静脉滴注给药,每日剂量为1至4克(多数为2克),疗程至少5天。根据上述标准评估,110例复杂性尿路感染患者中氨曲南的总体临床有效率为64%。按感染类型分组的有效率分别为:第一组38例患者中为66%,第二组3例中为33%,第三组19例中为79%,第四组21例中为85%,第五组19例中为47%,第六组12例中为42%。革兰氏阴性杆菌的清除率为87.1%。特别是25株铜绿假单胞菌中有15株(60%)在使用氨曲南后被清除。氨曲南治疗后出现46株菌株,其中36株(76%)为革兰氏阳性球菌。176例患者的主观副作用和实验室异常结果如下:腹泻1例,上腹部不适1例,谷丙转氨酶升高8例,谷草转氨酶升高5例,嗜酸性粒细胞增多1例。所有这些在停药后均消失。因此,氨曲南可能是治疗复杂性尿路感染的一种有用且安全的首选抗生素。

相似文献

1
[Clinical evaluation of aztreonam (AZT) in the treatment of complicated urinary tract infections].氨曲南(AZT)治疗复杂性尿路感染的临床评估
Hinyokika Kiyo. 1989 Dec;35(12):2155-61.
2
[Clinical evaluation of the combination of carumonam and cefotiam in the treatment of complicated urinary tract infection].卡芦莫南与头孢替安联合治疗复杂性尿路感染的临床评价
Hinyokika Kiyo. 1991 Feb;37(2):203-9.
3
[Clinical reevaluation of aztreonam (AZT) on urinary tract infections].
Hinyokika Kiyo. 1989 Apr;35(4):711-6.
4
[Clinical evaluation of aztreonam for complicated urinary tract infection].氨曲南治疗复杂性尿路感染的临床评估
Hinyokika Kiyo. 1985 Sep;31(9):1675-80.
5
[Clinical evaluation of ceftizoxime in the treatment of complicated urinary tract infections].头孢唑肟治疗复杂性尿路感染的临床评价
Hinyokika Kiyo. 1984 Oct;30(10):1519-29.
6
[Clinical efficacy of aztreonam in patients with complicated urinary tract infections].氨曲南治疗复杂性尿路感染患者的临床疗效
Hinyokika Kiyo. 1988 Dec;34(12):2225-32.
7
[Clinical evaluation of the combination of carumonam and fosfomycin in the treatment of complicated urinary tract infection].卡芦莫南与磷霉素联合治疗复杂性尿路感染的临床评价
Hinyokika Kiyo. 1990 Jun;36(6):731-5.
8
[Clinical evaluation of cefixime (CFIX) in the treatment of urinary tract infection].
Hinyokika Kiyo. 1989 Jul;35(7):1267-75.
9
[Well-controlled comparative study on aztreonam and cefoperazone in the treatment of complicated urinary tract infections].氨曲南与头孢哌酮治疗复杂性尿路感染的对照研究
Jpn J Antibiot. 1986 Jan;39(1):24-56.
10
[Clinical efficacy of tosufloxacin on the patients with urinary tract infections].妥舒沙星治疗尿路感染患者的临床疗效
Hinyokika Kiyo. 1992 Jan;38(1):129-34.